1. Role of epigenetics in OSCC: an understanding above genetics
   Priyanka P. Vatsa et al, 2023, Medical Oncology CrossRef
2. Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma
   Paramesh V. Karandikar et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
3. Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders
   Huamei Yang et al, 2020, Oral Diseases CrossRef
4. Effect of valproic acid on histone deacetylase expression in oral cancer (Review)
   Ahmed Al‑Khafaji et al, 2024, Oncology Letters CrossRef
5. DynOVis: a web tool to study dynamic perturbations for capturing dose-over-time effects in biological networks
   T. J. M. Kuijpers et al, 2019, BMC Bioinformatics CrossRef
6. The role of acetylation of histone H3 and H4 in oral squamous cell carcinoma
   Lian Li et al, 2023, Oncologie CrossRef
7. Expression and Prognosis Analysis of SUMOylation Regulators in Oral Squamous Cell Carcinoma Based on High-Throughput Sequencing
   Yutong Meng et al, 2021, Frontiers in Genetics CrossRef
8. Advances in the Histone Acetylation Modification in the Oral Squamous Cell Carcinoma
   Ying Lu et al, 2023, Journal of Oncology CrossRef
9. HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
   Eva Juengel et al, 2017, Oncotarget CrossRef
10. Anti-epileptic activity, toxicity and teratogenicity in CD1 mice of a novel valproic acid arylamide derivative, N-(2-hydroxyphenyl)-2-propylpentanamide
    José Melesio Cristóbal-Luna et al, 2020, Toxicology and Applied Pharmacology CrossRef
11. Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source
    Jure Krasic et al, 2020, Cancers CrossRef